All Stories

  1. Socioeconomic Disparities in Supportive Care Medication Use Among US Medicare Beneficiaries with Pancreatic Cancer
  2. Racial Disparities in Non-Stigmatized Supportive Care Medication Use in Pancreatic Cancer
  3. Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
  4. GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
  5. Tiered Training and Licensure for the Future of the Pharmacy Profession: Panacea or Pandora's Box?
  6. Data from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
  7. Supplemental Figure S1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
  8. Supplemental Table S1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
  9. Table 1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
  10. Table 2 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
  11. A fair machine learning model to predict flares of systemic lupus erythematosus
  12. Training the Next Generation of Researchers to Advance Cancer Health Equity: Five Years of Experience from the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
  13. Racial disparities in analgesic and psychiatric medication use during end-of-life care in advanced-stage colorectal cancer: A Retrospective Cohort Study
  14. Implementation and evaluation of a stop the bleed program at a college of pharmacy
  15. Regional trends and disparities in newer GLP1 receptor agonist initiation among real‐world adult patients eligible for obesity treatment
  16. Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services
  17. A change to the pathway: The Impact of the Supreme Court of the United States affirmative action decision on clinical pharmacy and a call to action for pharmacists
  18. Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes
  19. Data from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  20. Data from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  21. Supplemental Table 1 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  22. Supplemental Table 1 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  23. Supplemental Table 2 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  24. Supplemental Table 2 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  25. Clinical pharmacists addressing social determinants of health needs and eliminating health disparities: Bystander or change agent?
  26. Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies
  27. Community Champions: The Crucial Contribution of an Independent Pharmacy in COVID-19 Vaccination Efforts in an Underserved Community
  28. Implementing innovative teaching strategies to promote student academic engagement in a critical care elective
  29. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
  30. Curricular changes in times of crisis: Lessons learned
  31. Abstract A026: Disparities in the use of pain medication in patients with pancreatic cancer: Focus on racial and ethnic minorities
  32. Abstract A027: Evaluation of psychotropic medication usage patterns in patients with pancreatic cancer by race/ethnicity
  33. Abstract C026: Pharmacogenetics of pancreatic ductal adenocarcinoma: A review of racial disparities
  34. Evaluation of Potential Racial Disparities inCYP2C19‐Guided P2Y12Inhibitor Prescribing After Percutaneous Coronary Intervention
  35. A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist
  36. Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study
  37. Pharmacoequity and the clinical pharmacist: Why not us, why not now!
  38. Cognitive Testing of PAINReportIt-Spanish in Monolingual Hispanic Adults
  39. Pharmacy student self-assessment of strength of residency candidacy compared to clinical faculty
  40. Abstract PO-270: Evaluation of attitudes, beliefs and influences and their impact on HPV vaccination rates among minority health science students
  41. Pharmacokinetics in patients requiring renal replacement therapy
  42. Abstract PO-056: The ReTOOL training program for underrepresented minority students: Best practices for virtual training in midst of COVID-19
  43. 1435: EVALUATION OF BLACK-WHITE RACIAL DISPARITIES IN SEPSIS PATIENTS TREATED WITH PIPERACILLIN-TAZOBACTAM
  44. Addressing challenges of providing remote inpatient clinical pharmacy services
  45. Ten recommendations to increase Black representation within pharmacy organization leadership
  46. Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course
  47. 853: Comparison of Common Piperacillin-Tazobactam Dosing Strategies in Patients With Septic Shock
  48. 892: Impact of a Multimedia Approach to Rapid Response Team Training in a Pharmacy Critical Care Elective
  49. COVID-19 Therapeutics: Making Sense of It All
  50. Abstract D057: Impact of antibiotic exposure on the overall survival in patients receiving immune checkpoint inhibitors: Does race matter?
  51. 1382
  52. 960
  53. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock
  54. Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis
  55. Effect of prescriber peer comparison reports on fluoroquinolone use across a 16-facility community hospital system
  56. Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids
  57. 667
  58. Major publications in the critical care pharmacotherapy literature: January-December 2013
  59. Vasoactive Substances and Nutrition in Critical Care
  60. Vasoactive Substances and Nutrition in Critical Care
  61. Understanding Vasoactive Medications
  62. 914
  63. Abstracts and Index of Authors
  64. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population
  65. Ventriculoperitoneal Shunt Infections in Adult Patients
  66. Interpreting Laboratory Data
  67. Abstracts and Index of Authors
  68. Vasoactive Substances and Their Effects on Nutrition in the Critically Ill Patient
  69. Prevention, Recognition, and Management of Delirium in the Intensive Care Unit
  70. Evaluation of Recombinant Factor VIIa Off-Label Use at an Acute Care Hospital With Established Guidelines for Use